Telangiectasia, Hereditary Hemorrhagic
"Telangiectasia, Hereditary Hemorrhagic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.
Descriptor ID |
D013683
|
MeSH Number(s) |
C14.907.454.900 C14.907.823.780 C15.378.463.515.900 C16.131.240.850.968
|
Concept/Terms |
Telangiectasia, Hereditary Hemorrhagic- Telangiectasia, Hereditary Hemorrhagic
- Hemorrhagic Telangiectasia, Hereditary
- Hereditary Hemorrhagic Telangiectasia
- Telangiectasia, Hereditary Hemorrhagic, Type 1
- Osler-Weber-Rendu Syndrome
- Osler Weber Rendu Syndrome
- Telangiectasia, Hereditary Hemorrhagic, of Rendu, Osler, and Weber
- Osler-Rendu Disease
- Osler Rendu Disease
- Osler-Rendu-Weber Disease
- Osler Rendu Weber Disease
|
Below are MeSH descriptors whose meaning is more general than "Telangiectasia, Hereditary Hemorrhagic".
Below are MeSH descriptors whose meaning is more specific than "Telangiectasia, Hereditary Hemorrhagic".
This graph shows the total number of publications written about "Telangiectasia, Hereditary Hemorrhagic" by people in UAMS Profiles by year, and whether "Telangiectasia, Hereditary Hemorrhagic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2023 | 1 | 0 | 1 | 2021 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 | 2011 | 1 | 0 | 1 | 1995 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Telangiectasia, Hereditary Hemorrhagic" by people in Profiles over the past ten years.
-
Alkhalid Y, Darji Z, Shenkar R, Clancy M, Dyamenahalli U, Awad IA. Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Vasc Med. 2023 04; 28(2):153-165.
-
Al-Samkari H, Kasthuri RS, Parambil JG, Albitar HA, Almodallal YA, V?zquez C, Serra MM, Dupuis-Girod S, Wilsen CB, McWilliams JP, Fountain EH, Gossage JR, Weiss CR, Latif MA, Issachar A, Mei-Zahav M, Meek ME, Conrad M, Rodriguez-Lopez J, Kuter DJ, Iyer VN. An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study. Haematologica. 2021 08 01; 106(8):2161-2169.
-
Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, Deslandres E, Kasthuri RS, Lausman A, Poetker D, Ratjen F, Chesnutt MS, Clancy M, Whitehead KJ, Al-Samkari H, Chakinala M, Conrad M, Cortes D, Crocione C, Darling J, de Gussem E, Derksen C, Dupuis-Girod S, Foy P, Geisthoff U, Gossage JR, Hammill A, Heimdal K, Henderson K, Iyer VN, Kjeldsen AD, Komiyama M, Korenblatt K, McDonald J, McMahon J, McWilliams J, Meek ME, Mei-Zahav M, Olitsky S, Palmer S, Pantalone R, Piccirillo JF, Plahn B, Porteous MEM, Post MC, Radovanovic I, Rochon PJ, Rodriguez-Lopez J, Sabba C, Serra M, Shovlin C, Sprecher D, White AJ, Winship I, Zarrabeitia R. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med. 2020 12 15; 173(12):989-1001.
-
Arthur H, Geisthoff U, Gossage JR, Hughes CC, Lacombe P, Meek ME, Oh P, Roman BL, Trerotola SO, Velthuis S, Wooderchak-Donahue W. Executive summary of the 11th HHT international scientific conference. Angiogenesis. 2015 Oct; 18(4):511-24.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|